Short Summary
The PTAB instituted an IPR challenge against WellcomeMat, LLC's patent (8307286) concerning online video/real estate marketing. The Board found that the Petitioner met the reasonable likelihood standard despite prior district court litigation.
Detailed Summary
In this institution decision, the Patent Trial and Appeal Board ruled in favor of Aylo Freesites Ltd, instituting an IPR challenge against WellcomeMat, LLC's patent 8307286. The dispute centers on claims related to online video/real estate marketing, with grounds based on anticipation (102) by prior art such as Gupta and obviousness (103) over Kim, Vasilevsky, and Logan. Although the Patent Owner argued for discretionary denial citing parallel district court litigation in E.D. Tex., the Board determined that the Fintiv factors strongly weighed against denying institution, leading to the commencement of trial.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Aylo Freesites Ltd et al. vs WellcomeMat, LLC is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Intel Corporation et al.vsAdvanced Cluster Systems, Inc.
Intel and AMD have filed an IPR petition challenging all 30 claims of ACS’s ’621 patent covering parallel MATLAB execution on computer clusters, asserting obviousness over earlier Cornell publications and IBM documentation.
Tesla, Inc.vsGraphite Charging Company LLC
Tesla successfully navigated the PTAB's discretionary denial hurdles, leading to the institution of its IPR challenge against Graphite Charging Company LLC. The Board found that Tesla demonstrated a reasonable likelihood of prevailing on grounds of anticipation and obviousness over prior art references like Wang and Cooley.
Micron Technology, Inc. et al.vsYangtze Memory Technologies Company, Ltd.
The USPTO denied Micron Technology’s request for Director Review of the Final Written Decisions in three IPRs, including the case involving Yangtze Memory Technologies’ patent 10,950,623. The order affirms that the Director will not intervene.
Merck Sharp & Dohme LLCvsHalozyme, Inc. et al.
Merck challenges Halozyme’s PH20 enzyme patent, asserting that a 2013 publication anticipates all 18 claims and that the specification lacks written description and enablement. The petition seeks inter partes review under § 102 and § 112(a).
Tessell, Inc.vsNutanix, Inc.
The PTAB denied Tessell's petitions for Director Review of the institution decisions in two IPRs involving Nutanix patents, leaving the institution denials intact.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.